CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.24% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
3928.1
4.37%
Market Trading Hours* (UTC) Opens on Thursday at 00:00

Mon - Fri: 00:00 - 02:30 03:30 - 06:25

  • Summary
  • Historical Data
Trading сonditions
Spread 10.8
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.012355 %
Charges from full value of position ($-2.35)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.012355%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.009867 %
Charges from full value of position ($-1.87)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.009867%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5.00%
Stock exchange Japan
Commission on trade 0%

Key Stats
Prev. Close 4107.7
Open 4047.3
1-Year Change -33.27%
Day's Range 3927.1 - 4047.3
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 2, 2025 3963.3 -140.7 -3.43% 4104.0 4112.9 3946.6
Apr 1, 2025 4107.7 -37.2 -0.90% 4144.9 4177.8 4100.5
Mar 31, 2025 4147.9 -73.4 -1.74% 4221.3 4221.3 4135.5
Mar 28, 2025 4298.6 15.3 0.36% 4283.3 4312.6 4258.3
Mar 27, 2025 4357.1 46.4 1.08% 4310.7 4357.8 4304.2
Mar 26, 2025 4313.6 17.9 0.42% 4295.7 4341.9 4292.8
Mar 25, 2025 4318.7 10.0 0.23% 4308.7 4326.7 4288.8
Mar 24, 2025 4310.1 -28.0 -0.65% 4338.1 4359.1 4307.1
Mar 21, 2025 4321.8 9.1 0.21% 4312.7 4343.7 4281.2
Mar 19, 2025 4338.1 18.0 0.42% 4320.1 4371.0 4316.1
Mar 18, 2025 4300.7 -25.2 -0.58% 4325.9 4334.7 4279.2
Mar 17, 2025 4298.7 31.8 0.75% 4266.9 4315.1 4260.2
Mar 14, 2025 4267.8 42.8 1.01% 4225.0 4274.1 4211.2
Mar 13, 2025 4243.8 -2.4 -0.06% 4246.2 4263.0 4219.2
Mar 12, 2025 4253.8 22.0 0.52% 4231.8 4267.6 4200.2
Mar 11, 2025 4258.8 0.0 0.00% 4258.8 4290.1 4237.2
Mar 10, 2025 4275.8 50.7 1.20% 4225.1 4281.8 4225.1
Mar 7, 2025 4231.8 -38.9 -0.91% 4270.7 4270.7 4206.2
Mar 6, 2025 4292.2 34.0 0.80% 4258.2 4303.1 4240.8
Mar 5, 2025 4247.2 0.4 0.01% 4246.8 4280.0 4218.2

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Eisai Co., Ltd. Company profile

About Eisai Co., Ltd

Eisai Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Eisai Co., Ltd revenues increased 13% to Y565.33B. Net income applicable to common stockholders increased 34% to Y60.36B. Revenues reflect Other Business segment increase from Y43.85B to Y92.54B, Pharmaceutical Business segment increase of 3% to Y449.48B, China segment increase of 25% to Y83.14B, America segment increase of 13% to Y125.19B, Asia/Latin America segment increase of 10% to Y38.04B.

Equity composition

FY'99-02 WAS & FY'04 DWAS were estimated. FY'03 DWAS was adjusted to reflect reported DEPS. FY'04-06 1Q&3Q WAS & O/S were estimated. 12/05 DPS estimated. FY'08 Q1&Q3 DWAS were estimated. FY'08 Q1&Q3 WAS = O/S. FY'11 Q3 DWAS estimated.

Industry: Pharmaceuticals (NEC)

エーザイ本館
小石川4-6-10
BUNKYO-KU
TOKYO-TO 112-8088
JP

People also watch

BTC/USD

86,555.25 Price
+1.570% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

US100

19,501.90 Price
+0.520% 1D Chg, %
Long position overnight fee -0.0237%
Short position overnight fee 0.0015%
Overnight fee time 21:00 (UTC)
Spread 1.8

XRP/USD

2.15 Price
+0.420% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01073

ETH/USD

1,903.25 Price
-0.600% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading